Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for nsaids
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on nsaids or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on nsaids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints: a systematic review The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints: a systematic review The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints: a systematic review van der Windt D A, van der Heijden G J, Scholten R J, Koes B W, Bouter L M Authors' objectives To examine the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs (...) designs of evaluations included in the review Randomised controlled trials (RCTs) were included. Specific interventions included in the review NSAIDs, either compared to placebo or to other treatment modalities, or to another NSAID. A variety of drugs were studied including naproxen, diclofenac and flurbiprofen. Participants included in the review At least 90% of the study population had to be patients with intrinsic shoulder complaints which included bursitis, tendinitis, periarthritis and capsulitis
[Cost-effectiveness of misoprostol administration in the prevention of NSAID-induced gastric ulcer] Die Kosten-Effektivitat der Misoprostoltherapie in der Pravention NSAR-induzierter Magenulzera [Cost-effectiveness of misoprostol administration in the prevention of NSAID-induced gastric ulcer] Die Kosten-Effektivitat der Misoprostoltherapie in der Pravention NSAR-induzierter Magenulzera [Cost-effectiveness of misoprostol administration in the prevention of NSAID-induced gastric ulcer] Schwarz B (...) Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The administration of misoprostol, a prostaglandin E analog, to patients already taking non-steroidal anti-inflammatory drugs (NSAID) in order to prevent the incidence of gastric
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. A double-blind, placebo-controlled study was carried out to see whether the synthetic E prostaglandin, misoprostol, would prevent gastric ulcer induced by non-steroidal anti-inflammatory drugs (NSAIDs). 420 patients with osteoarthritis and NSAID-associated abdominal pain were studied; they were receiving ibuprofen, piroxicam, or naproxen. Endoscopy was done at entry and after 1, 2 (...) , and 3 months of continuous treatment with 100 micrograms or 200 micrograms misoprostol or placebo, given four times daily with meals and at bedtime, concurrently with the NSAID. Abdominal pain was rated independently by patients and physicians. A treatment failure was defined as development of a gastric ulcer. Gastric ulcers (0.3 cm in diameter or greater) occurred less frequently (p less than 0.001) in both misoprostol treatment groups (5.6% 100 micrograms and 1.4% 200 micrograms) than